Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): EQ-5D, EORTC QLQ-C30 and LMC21 results from the FOXFIRE study

Jane Wolstenholme,Andrew Wotherspoon,Paul Tait,Val Lewington,Bruno Morgan,Sharon Love,Luise Dunham,Harpreet Wasan,Alastair Gray,Adil Al-Nahhas,Ian Chau,Sarah Pearson,Val Gebski,Peter Gibbs,Joanna Moschandreas,Nasir Khan,David P Berry ,Gregory Wilson,P S Virdee ,A N Roberts ,Anne Francis ,G Van Hazel ,Francesco Fusco,Ricky A Sharma

doi:10.1016/j.ejso.2018.01.568

Abstract

Background: Little is known about quality of life (QoL) in colorectal cancer patients with liver metastases treated with selective internal radiotherapy (SIRT) using Yttrium-90 resin microspheres combined with FOLFOX (standard chemotherapy) compared to FOLFOX alone. We report QoL results from a multicentre randomized trial: FOXFIRE.

Full Text